Acadia Pharmaceuticals buy tamam
Start price
23.02.18
/
50%
€27.40
Target price
25.02.19
€43.93
Performance (%)
-26.04%
End price
25.02.19
€20.27
Summary
This prediction ended on 25.02.19 with a price of €20.27. The price of Acadia Pharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.04%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acadia Pharmaceuticals | 0.409% | 0.409% | -12.814% | -5.815% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
Comments by tamam for this prediction
In the thread Acadia Pharmaceuticals diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 23.02.2018 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 48.7$ zu.
(Laufzeit überschritten)
Stopped prediction by tamam for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€35.70
26.01.20
26.01.20
€52.00
04.11.21
04.11.21
-51.51%
05.11.21
05.11.21
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€39.17
14.01.20
14.01.20
€48.00
26.01.20
26.01.20
-8.85%
26.01.20
26.01.20
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€39.05
18.12.19
18.12.19
€46.00
14.01.20
14.01.20
-1.97%
14.01.20
14.01.20
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€33.10
07.03.17
07.03.17
€34.28
23.02.18
23.02.18
-17.60%
23.02.18
23.02.18
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€30.48
22.04.16
22.04.16
€43.30
22.06.16
22.06.16
-0.90%
22.06.16
22.06.16